SGLT-2 inibitori alla luce delle nuove linee guida italiane per il trattamento del diabete di tipo 2: un trattamento-costo efficace? | Zendy

AI Assistant Blog Pricing

Open Access

SGLT-2 inibitori alla luce delle nuove linee guida italiane per il trattamento del diabete di tipo 2: un trattamento-costo efficace?

Author(s) -

Matteo Monami

Publication year - 2021

Publication title -

il diabete

Language(s) - Italian

Resource type - Journals

eISSN - 1720-8335

pISSN - 0394-901X

DOI - 10.30682/ildia2104d

Subject(s) - medicine , humanities , philosophy

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research

Address

John Eccles House
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom

About

About Careers Publisher Partners Contact Us Get Organisational Trial or Quote

Learn

FAQs Blog Terms of Use Privacy Policy

Download the Zendy App

Download on the

Discover

Explore

Copyright Knowledge E © 2026. All Rights Reserved.